On 19 March 2015, orphan designation (EU/3/15/1464) was granted by the European Commission to Assistance Publique Hôpitaux de Marseille, France, for autologous adipose tissue-derived stromal vascular fraction cells for the treatment of systemic sclerosis.

Key facts

Active substance
Autologous adipose tissue-derived stromal vascular fraction cells
Disease / condition
Treatment of systemic sclerosis
Date of first decision
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Assistance Publique Hôpitaux de Marseille
80 rue Brochier
13354 Marseille cedex 5
Tel. +33 4 91 38 13 12
Fax +33 4 91 38 14 79

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating